Alligator Bioscience

Alligator Bioscience discovers and develops innovative antibody based immunotherapies for the treatment of cancer.

In the discovery of novel antibody based drugs, Alligator uses its proprietary technology platforms ALLIGATOR-GOLD® and FIND®: ALLIGATOR-GOLD® is a synthetic svFv library containing several billion distinct fully human antibodies. FIND® (Fragment Induced Diversity) is an antibody optimization technology based on single-stranded DNA allowing generation of antibodies with significant clinical benefits. Alligator Bioscience AB was founded in 2001 and is a privately held company located at Medicon Village in Lund, Sweden.